GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexstim Oyj (OHEL:NXTMH) » Definitions » Capex-to-Revenue

Nexstim Oyj (OHEL:NXTMH) Capex-to-Revenue : 0.13 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Nexstim Oyj Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Nexstim Oyj's Capital Expenditure for the six months ended in Dec. 2023 was €-0.62 Mil. Its Revenue for the six months ended in Dec. 2023 was €4.74 Mil.

Hence, Nexstim Oyj's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.13.


Nexstim Oyj Capex-to-Revenue Historical Data

The historical data trend for Nexstim Oyj's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexstim Oyj Capex-to-Revenue Chart

Nexstim Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.05 0.25 0.15 0.21

Nexstim Oyj Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.11 0.25 0.35 0.13

Competitive Comparison of Nexstim Oyj's Capex-to-Revenue

For the Medical Devices subindustry, Nexstim Oyj's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nexstim Oyj's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nexstim Oyj's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nexstim Oyj's Capex-to-Revenue falls into.



Nexstim Oyj Capex-to-Revenue Calculation

Nexstim Oyj's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.489) / 7.246
=0.21

Nexstim Oyj's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.621) / 4.743
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nexstim Oyj  (OHEL:NXTMH) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Nexstim Oyj Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nexstim Oyj's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nexstim Oyj (OHEL:NXTMH) Business Description

Traded in Other Exchanges
Address
Elimaenkatu 9 B, Helsinki, FIN, FI-00510
Nexstim Oyj is medical technology company. The company has developed a non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with 3D navigation providing accurate and personalized targeting of TMS to the specific area of the brain. The company earns revenue in Finland, Rest of Europe, North America and Other. The majority of revenue is earned in Finland.

Nexstim Oyj (OHEL:NXTMH) Headlines

No Headlines